BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 3109734)

  • 1. Loss of a Hu-ets-1 allele in human leukemia cell lines ML-1, -2, and -3 with a chromosome change at 11q24.
    Ohyashiki K; Ohyashiki JH; Sandberg AA; Minowada J; Kinniburgh AJ
    Cancer Res; 1987 Jul; 47(14):3842-6. PubMed ID: 3109734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosome abnormalities in leukemia and lymphoma.
    Rowley JD
    Ann Clin Lab Sci; 1983; 13(2):87-94. PubMed ID: 6602585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of cell surface membrane antigens common to both human neuroblastoma and leukemia-lymphoma cell lines by a panel of 38 monoclonal antibodies.
    Sugimoto T; Tatsumi E; Kemshead JT; Helson L; Green AA; Minowada J
    J Natl Cancer Inst; 1984 Jul; 73(1):51-7. PubMed ID: 6610792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell surface differentiation antigens of the malignant T cell in Sezary syndrome and mycosis fungoides.
    Haynes BF; Bunn P; Mann D; Thomas C; Eisenbarth GS; Minna J; Fauci AS
    J Clin Invest; 1981 Feb; 67(2):523-30. PubMed ID: 6970206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular evolution of ets genes from avians to mammals and their cytogenetic localization to regions involved in leukemia.
    Papas TS; Watson DK; Sacchi N; O'Brien SJ; Ascione R
    Gene Amplif Anal; 1986; 4():207-38. PubMed ID: 3333359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human T cell gamma-chain gene rearrangements in acute lymphoid and nonlymphoid leukemia: comparison with the T cell receptor beta-chain gene.
    Greenberg JM; Quertermous T; Seidman JG; Kersey JH
    J Immunol; 1986 Sep; 137(6):2043-9. PubMed ID: 3489046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
    Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
    J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetic characterization of putative human myeloblastic leukemia cell lines (ML-1, -2, and -3): origin of the cells.
    Ohyashiki K; Ohyashiki JH; Sandberg AA
    Cancer Res; 1986 Jul; 46(7):3642-7. PubMed ID: 3458526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amplification and rearrangement of Hu-ets-1 in leukemia and lymphoma with involvement of 11q23.
    Rovigatti U; Watson DK; Yunis JJ
    Science; 1986 Apr; 232(4748):398-400. PubMed ID: 3457468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional characterization of human T lymphocyte subsets distinguished by monoclonal anti-leu-8.
    Kansas GS; Wood GS; Fishwild DM; Engleman EG
    J Immunol; 1985 May; 134(5):2995-3002. PubMed ID: 3156924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hu-ets-1 gene in congenital leukemia with t(11;19)(q23;p13).
    Ohyashiki K; Ohyashiki JH; Nomura K; Ryan DH; Kinniburgh AJ; Sandberg AA
    Cancer Genet Cytogenet; 1988 Feb; 30(2):233-8. PubMed ID: 2830011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the human T cell lymphoma virus in B cell lines established from patients with adult T cell leukemia.
    Mann DL; Clark J; Clarke M; Reitz M; Popovic M; Franchini G; Trainor CD; Strong DM; Blattner WA; Gallo RC
    J Clin Invest; 1984 Jul; 74(1):56-62. PubMed ID: 6330177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody-defined B-cell, T-cell and myelomonocytic antigens and other surface determinants on leukemic B cells of chronic lymphocytic leukemia.
    Han T; Ozer H; Minowada J
    Prog Clin Biol Res; 1983; 133():135-44. PubMed ID: 6604920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of cell surface antigens induced by 12-O-tetradecanoyl-phorbol 13-acetate in two myeloblastic cell lines, a promyelocytic cell line, and a monoblastic cell line: detection with five monoclonal antibodies.
    Sugimoto T; Tatsumi E; Takeda K; Minato K; Sagawa K; Minowada J
    J Natl Cancer Inst; 1984 Apr; 72(4):923-8. PubMed ID: 6368942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
    Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
    Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
    Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rearrangements of the mixed lineage leukemia gene in acute myeloid leukemia].
    Zhang LJ; Lu XL; He J; Li Y
    Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(32):2256-60. PubMed ID: 17064570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosomal changes detected by fluorescence in situ hybridization in patients with acute lymphoblastic leukemia.
    Zhang L; Parkhurst JB; Kern WF; Scott KV; Niccum D; Mulvihill JJ; Li S
    Chin Med J (Engl); 2003 Sep; 116(9):1298-303. PubMed ID: 14527352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Pan-myeloid" reagent: the monoclonal antibody MCS-2 in the routine immunodiagnostic service of leukemia phenotyping.
    Drexler HG; Sagawa K; Menon M; Minowada J
    Jpn J Cancer Res; 1985 Mar; 76(3):235-9. PubMed ID: 3922842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Specific chromosomal changes (aberrations)--supplementary marker of malignant degeneration in oncomorphologic studies].
    Anichkov NM; Mamaev NN; Mamaeva SE; Skripnik SV
    Arkh Patol; 1986; 48(6):87-91. PubMed ID: 3530204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.